Re-posted. because Yahoo published the the original post incorrectly ---
___It always makes me laugh when "self-proclaimed experts" think they know an industry better than the people who push the buttons. Spencer Osborne (or whatever name he is using today) is that kind of shallow-minded analyst type who cost investors $2.61- a year ago to $7.56 on a bad close, like today. It really blows to triple your money in a year.
Now his latest and probably recurring FUD theme is wait for sales, wait for sales wait for sales. OK you wait and pay $18.00 like every other late comer will
Does Spencer really think that 30,000 doctors being courted by Eisai reps for a year dont know the score?
Does Spencer really think that a company with $2,2 B in the bank and a quarter of a billion on the table is going to leave sales to chance?
Does Spencer really think that the clinics every chain pharmacy in the US are not going to tell obese patients to get on a safe program?
Does Spencer really think that outfits like Medifast, Jenny Craig, Weightwatchers wont bring their own MDs aboard?
Does Spencer really think the safety profile and unrestricted sales channels wont make things different for Belviq over Qysmia?
Does Spencer really think that the rest of the Arena pipeline may be of more interest to majors than Belviq?
Dont worry about the sales Spencer, worry about traders finding out what your real game is.
Sentiment: Strong Buy
you have very succintly and effectively laid out what we all know. but it isnt good enough. strong wall street forces have put a lid on this stock and have been effective at every turn in forcing the stock down. in case you didnt notice, the stock did not have a big pop when dea scheduling finally occurred. in fact it has been beaten down below 8. at the same time Q reports continuing dismal sales and it is rising. the market cap gap is narrower. listening to the market is important. it is not fond of arna. as a long i am astounded by this. and earlier i predicted by this time the shackles would be lifted. now having experienced the incredibel delay in scheduling which has allowed vvus to pick the low hanging fruit, i know it is going to be difficutl to get sales going quickly and the shorts will drive the stock down further. so our only hope is sales, but that wont come immediately. strong sales will be the only means of overcoming the enormous wall strret negativity overwhelming this stock. so yes it is sales. and we need to pray because most new drugs take a while to ramp up.
the rest of the Arena pipeline may be of more interest to majors than Belviq? Dont worry about the sales Spencer, worry about traders finding out what your real game is.